Download PowerPoint File, 2.76 MB

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
(Relates to Chapter 37, “Nursing Management:
Inflammatory and Structural Heart Disorders,” in the
textbook)
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Infection
of the inner layer of the heart
that usually affects the cardiac valves
 Was almost always fatal until
development of penicillin
 15,000 cases diagnosed in the
United States each year
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
Fig. 37-1
 Subacute
form
• Longer clinical course
• Insidious onset
• Caused by enterococci
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Acute
form
• Shorter clinical course
• Rapid onset
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Causative
organism more virulent
 Streptococcus viridans
 Staphylococcus aureus
 Viruses
 Fungi
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Occurs
when blood turbulence within
heart allows causative agent to infect
previously damaged valves or other
endothelial surfaces
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Principal
risk factors
• Prior endocarditis
• Prosthetic valves
• Acquired valvular disease
• Cardiac lesions
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Vegetation
• Fibrin, leukocytes, platelets, and microbes
• Adhere to the valve or endocardium
• Embolization of portions of vegetation
into circulation
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
Fig. 37-2
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
Fig. 37-3
 Nonspecific
 Fever
occurs in 90% of patients
 Chills
 Weakness
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Malaise
 Fatigue
 Anorexia
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Subacute
form
• Arthralgias
• Myalgias
• Back pain
• Abdominal discomfort
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Subacute
form
• Weight loss
• Headache
• Clubbing of fingers
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Vascular
manifestations
• Splinter hemorrhages in nail beds
• Petechiae
• Osler’s nodes on fingers or toes
• Janeway’s lesions on palms or soles
• Roth’s spots
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Murmur
in most patients
 Heart failure in up to 80% with aortic
valve endocarditis
 Manifestations secondary to embolism
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 History
• Recent dental, urologic, surgical, or
gynecologic procedures
• Heart disease
• Recent cardiac catheterization
• Skin, respiratory, or urinary tract infection
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Laboratory
tests
• Blood cultures
• WBC with differential
 Echocardiography
 Chest
x-ray
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Prophylactic
treatment for patients
having
• Removal or drainage of infected tissue
• Renal dialysis
• Ventriculoatrial shunts
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Antibiotic
administration
• Monitor antibiotic serum levels
• Subsequent blood cultures
• Renal function monitored
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Fungal
and prosthetic valve
endocarditis
• Responds poorly to antibiotics
• Valve replacement is adjunct procedure
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Subjective
Data
• History of valvular, congenital, or
syphilitic cardiac disease
• Previous endocarditis
• Staph or strep infection
• Immunosuppressive therapy
• Recent surgeries and procedures
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Functional
health patterns
• IV drug abuse
• Alcohol abuse
• Weight changes
• Chills
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
• Diaphoresis
• Bloody urine
• Exercise intolerance
• Generalized weakness
• Fatigue
• Cough
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
• Dyspnea on exertion
• Night sweats
• Chest, back, abdominal pain
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Objective
Data
• Olser’s nodes
• Splinter hemorrhage
• Janeway’s lesions
• Petechiae
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Objective
Data
• Clubbing
• Tachypnea
• Crackles
• Dysrhythmias
• Tachycardia
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Objective
Data
• Leukocytosis
• Anemia
• ↑ ESR and cardiac enzymes
• Positive cultures
• ECG showing chamber enlargement
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Patient
will
• Have normal cardiac function
• Perform ADLs without fatigue
• Understand therapeutic regimen to
prevent recurrence
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Identify
those at risk
 Assessment of history and
understanding of disease process
 Teach importance of adherence to
treatment regimen
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Stress
need to avoid infectious people
 Avoidance of stress and fatigue
 Rest
 Hygiene
 Nutrition
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Assessment
of nonspecific
manifestations
 Monitor laboratory data
 Monitor patency of IV
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Compression
stockings with
immobility
 ROM
 Turn, cough, deep breathe
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Teach
signs and symptoms of infection
 Teach reduction measures for risk for
infection
 Stress follow-up care
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Vital
signs WNL
 Absence of chills, diaphoresis,
headache
 Sufficient cardiac output
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
 Completion of ADLs
with no fatigue or
physiologic distress
 Increased understanding of disease
process and self-care management
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
Related documents